Exploring the Potential Antidepressant Mechanisms of Pinellia by Using the Network Pharmacology and Molecular Docking

Overview

Journal Metab Brain Dis

Publisher Springer

Specialties Endocrinology
Neurology

Date 2022 Mar 1

PMID 35230627

Authors

Yu-Gang Xiao

Han-Biao Wu

Ji-Sheng Chen

Xiong Li

Zhi-Kun Qiu

Affiliations

Soon will be listed here.

Abstract

About 350 million people worldwide suffered from depression, but less than half of the patients received effective and regular treatments. Traditional Chinese Medicine (TCM) such as pinellia has been proven effective for antidepressant treatment with fewer side effects. However, the exact mechanisms remain unclear. Herein, we use the methods of network pharmacology and molecular docking to analyze the effective monomer components of pinellia and reveal the involved signaling pathways to produce antidepressant effects. TCMSP, BATMAN-TCM, and TCMID databases were utilized to analyze the bioactive ingredients and target genes derived from pinellia via the screening the molecular weight (MW), oral bioavailability (OB), blood-brain barrier (BBB) and drug similarity (DL). OMIM, TTD, DisGeNET, GeneCards and DrugBank databases were used to obtain key genes of depression. Then, the networks of protein-protein interaction (PPI) and "medicine-ingredients-targets-pathways" were built. The target signaling pathways were enriched by GO and KEGG by using R language. Furthermore, bioactive ingredients binding of the targets were verified by molecular docking. Nine active monomer ingredients and 96 pivotal gene targets were selected from pinellia. 10,124 disease genes and 87 drug-disease intersecting genes were verified. GO analysis proposed that the receptor activity of neurotransmitter, postsynaptic neurotransmitter, G protein-coupled neurotransmitter, and acetylcholine through the postsynaptic membrane could be modulated by pinellia. KEGG pathway analysis revealed that pinellia influenced depression-related neural tissue interaction, cholinergic synapse, serotonin activated synapse and calcium signaling pathway. Besides, the reliability and accuracy of results obtained from the indirect network pharmacology were validated by molecular docking. The bioactive components of pinellia made significant antidepressant effects by regulating the key target genes/proteins in the pathophysiology of depression.

Citing Articles

Xiao-Chai-Hu-Tang Ameliorates Depressive Symptoms via Modulating Neuro-Endocrine Network in Chronic Unpredictable Mild Stress-Induced Mice.

Feng Y, Wang W, Zhang Y, Feng Y, Zhao Y, Zhang Z CNS Neurosci Ther. 2025; 31(2):e70290.

PMID: 39981856 PMC: 11843474. DOI: 10.1111/cns.70290.

Characterization of GABAergic marker expression in prefrontal cortex in dexamethasone induced depression/anxiety model.

Ling Hu , Qiu M, Fan W, Wang W, Liu S, Liu X Front Endocrinol (Lausanne). 2024; 15:1433026.

PMID: 39483976 PMC: 11524930. DOI: 10.3389/fendo.2024.1433026.

Ridge planting increases the rhizosphere microbiome diversity and improves the yield of Pinellia ternata (Thunb.) Breit in North China.

Li Y, An J, Guo J, Dang Z, Gao Z PLoS One. 2024; 19(9):e0304898.

PMID: 39269967 PMC: 11398693. DOI: 10.1371/journal.pone.0304898.

Antidepressant-like Effects of Chinese Quince () Fruit Based on In Vivo and Molecular Docking Studies.

Lim D, Yoo G, Kim Y, Lee C Int J Mol Sci. 2024; 25(11).

PMID: 38892026 PMC: 11172133. DOI: 10.3390/ijms25115838.

Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking.

Alte G, Rodrigues A Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513925 PMC: 10383558. DOI: 10.3390/ph16071013.

References

Alavi M, Shamsizadeh A, Azhdari-Zarmehri H, Roohbakhsh A . Orphan G protein-coupled receptors: The role in CNS disorders. Biomed Pharmacother. 2017; 98:222-232. DOI: 10.1016/j.biopha.2017.12.056. View

Amberger J, Bocchini C, Schiettecatte F, Scott A, Hamosh A . OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 2014; 43(Database issue):D789-98. PMC: 4383985. DOI: 10.1093/nar/gku1205. View

Babb J, Linnros S, Commons K . Evidence for intact 5-HT receptor-mediated feedback inhibition following sustained antidepressant treatment in a rat model of depression. Neuropharmacology. 2018; 141:139-147. PMC: 6170686. DOI: 10.1016/j.neuropharm.2018.08.032. View

Boschloo L, Schoevers R, Beekman A, Smit J, van Hemert A, Penninx B . The four-year course of major depressive disorder: the role of staging and risk factor determination. Psychother Psychosom. 2014; 83(5):279-88. DOI: 10.1159/000362563. View

Bromet E, Andrade L, Hwang I, Sampson N, Alonso J, de Girolamo G . Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011; 9:90. PMC: 3163615. DOI: 10.1186/1741-7015-9-90. View

Burley S, Berman H, Christie C, Duarte J, Feng Z, Westbrook J . RCSB Protein Data Bank: Sustaining a living digital data resource that enables breakthroughs in scientific research and biomedical education. Protein Sci. 2017; 27(1):316-330. PMC: 5734314. DOI: 10.1002/pro.3331. View

Chen L, Zhang Y, Wang S, Zhang Y, Huang T, Cai Y . Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PLoS One. 2017; 12(9):e0184129. PMC: 5584762. DOI: 10.1371/journal.pone.0184129. View

Chen X, Ji Z, Chen Y . TTD: Therapeutic Target Database. Nucleic Acids Res. 2001; 30(1):412-5. PMC: 99057. DOI: 10.1093/nar/30.1.412. View

Dvojkovic A, Nikolac Perkovic M, Sagud M, Nedic Erjavec G, Mihaljevic Peles A, Strac D . Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 105:110016. DOI: 10.1016/j.pnpbp.2020.110016. View

10.

El Yacoubi M, Vaugeois J, Jamain S . Antidepressant-like effect of low dose of scopolamine in the H/Rouen genetic mouse model of depression. Fundam Clin Pharmacol. 2020; 35(4):645-649. DOI: 10.1111/fcp.12639. View

11.

Fatima M, Ahmad M, Srivastav S, Rizvi M, Mondal A . A selective D2 dopamine receptor agonist alleviates depression through up-regulation of tyrosine hydroxylase and increased neurogenesis in hippocampus of the prenatally stressed rats. Neurochem Int. 2020; 136:104730. DOI: 10.1016/j.neuint.2020.104730. View

12.

Feng D, Tang T, Lin X, Yang Z, Yang S, Xia Z . Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology review. Neuropsychiatr Dis Treat. 2016; 12:2387-2402. PMC: 5036551. DOI: 10.2147/NDT.S114560. View

13.

Ghorpade S, Tripathi R, Sonawane D, Manjrekar N . Evaluation of antidepressant activity of ropinirole coadministered with fluoxetine in acute and chronic behavioral models of depression in rats. J Basic Clin Physiol Pharmacol. 2012; 22(4):109-14. DOI: 10.1515/JBCPP.2011.027. View

14.

Grammatopoulos D . Regulation of G-protein coupled receptor signalling underpinning neurobiology of mood disorders and depression. Mol Cell Endocrinol. 2017; 449:82-89. DOI: 10.1016/j.mce.2017.02.013. View

15.

Harmer C, Duman R, Cowen P . How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017; 4(5):409-418. PMC: 5410405. DOI: 10.1016/S2215-0366(17)30015-9. View

16.

Hasbi A, Fan T, Alijaniaram M, Nguyen T, Perreault M, ODowd B . Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth. Proc Natl Acad Sci U S A. 2009; 106(50):21377-82. PMC: 2795506. DOI: 10.1073/pnas.0903676106. View

17.

Herdegen T, Sandkuhler J, Gass P, Kiessling M, Bravo R, Zimmermann M . JUN, FOS, KROX, and CREB transcription factor proteins in the rat cortex: basal expression and induction by spreading depression and epileptic seizures. J Comp Neurol. 1993; 333(2):271-88. DOI: 10.1002/cne.903330212. View

18.

Hermann D, Mies G, Hossmann K . Expression of c-fos, junB, c-jun, MKP-1 and hsp72 following traumatic neocortical lesions in rats--relation to spreading depression. Neuroscience. 1999; 88(2):599-608. DOI: 10.1016/s0306-4522(98)00249-8. View

19.

Hopkins A . Network pharmacology: the next paradigm in drug discovery. Nat Chem Biol. 2008; 4(11):682-90. DOI: 10.1038/nchembio.118. View

20.

Huang C, Zheng C, Li Y, Wang Y, Lu A, Yang L . Systems pharmacology in drug discovery and therapeutic insight for herbal medicines. Brief Bioinform. 2013; 15(5):710-33. DOI: 10.1093/bib/bbt035. View